This expert-led workshop will show you how to turn regulatory alerts into actionable intelligence using trusted sources, practical prioritization, and clear internal communication.
This instructor-led workshop will equip regulatory professionals with practical strategies to build and strengthen a regulatory intelligence function, regardless of budget or access to sophisticated platforms. Participants will learn how to identify high-value, trustworthy sources; distinguish regulatory monitoring from regulatory intelligence; and apply prioritization frameworks to reduce noise and focus on changes with operational impact.
Through guided discussion and live examples, the session will demonstrate approaches for interpreting global regulatory updates, assessing business and operational relevance, and translating findings into clear, actionable communications for internal teams. The session will also introduce scalable, low-cost approaches for structuring insights, tracking decisions, and supporting regulatory and operational alignment.
Designed for professionals working in small teams, emerging markets, or resource-constrained settings, this workshop will help attendees increase the value and visibility of regulatory intelligence using practical, accessible approaches that do not depend on advanced tools or large-scale systems.
Upon the conclusion of the program, you will be able to:
This workshop will benefit these regulatory professionals involved in monitoring, interpreting, or communicating regulatory updates and translating them into actionable internal guidance:
Intermediate: Content is designed based upon the assumption that individuals have basic knowledge of the topic(s) and/or demonstrated competence related to the topic(s). Higher-level concepts are introduced during lectures; exercises requiring synthesis and/or application of concepts are incorporated into the activity.
RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation. All cancellation requests must be submitted in writing to [email protected]. Cancellations will receive a full refund minus a 20% administrative fee. RAPS is unable to accept cancellations by phone.
Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email [email protected] with the event title, name of the original registrant and the contact information for the new attendee.
A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.
Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email [email protected].



Director, Global Regulatory Affairs, Florence Healthcare
Sara Saunders is the director of global regulatory affairs at Florence Healthcare, where she leads global compliance and regulatory strategy to enable decentralized and hybrid clinical trials. With extensive experience across vendor and site environments, Sara specializes in translating complex global regulatory frameworks into practical, scalable digital solutions. At Florence, she drives international regulatory alignment for computerized systems and supports global expansion initiatives, ensuring compliance with evolving regulatory expectations. Her work is grounded in regulatory intelligence and patient-centricity, positioning her as a trusted voice in advancing digital research ecosystems. Sara frequently shares insights on regulatory innovation at industry conferences and contributes to cross-border dialogue on harmonization and modernization.

Senior Global Regulatory Analyst, Florence Healthcare
Kimberly Gallop is the senior global regulatory analyst at Florence Healthcare, bringing 13 years of clinical research experience with a strong foundation in global regulatory affairs and clinical trial start-up operations at a major CRO. In her role, she oversees the Regulatory Compliance Library, ensuring alignment with international standards such as ICH GCP E6(R2), FDA 21 CFR Part 11, EMA Annex 11, and MHRA guidance. Kimberly provides regulatory insight and consultation to software development teams, guiding product compliance with both internal policies and external regulations. She collaborates with subject matter experts to research and interpret global clinical research requirements, and plays a critical role in internal audits to ensure Florence maintains the highest standards of regulatory compliance.